Cost Savings Reason for 60% of Outsourced Pharma and Bio Manufacturing

June 2, 2011
U.S. largest regional market for contract manufacturing.

While 54.5% of pharma and biopharm companies outsource less than half of their global manufacturing, 18.2% currently use outsourcing for at least 91% of their output, according to a recent survey by Pharma IQ.

Interestingly, the U.S. represents the largest regional market for contract manufacturing. Europe comes in second with future growth expected from developing regions, especially Asia Pacific. "The Japanese market for pharmaceutical contract manufacturers is projected to register annual growth rate of 12.8% during the next four years," according to the study.

An earlier report from Global Industry Analysts predicted that the global pharmaceutical contract manufacturing market would reach a total value in excess of $40.7 billion by 2015.

The key factors driving such expansion included soaring demand for new drugs, increasing need for R&D productivity and efficiency, as well as the desire to make cost savings where possible. Another reason is that many pharma and biotech companies simply lack sufficient manufacturing capabilities internally. In fact, the Pharma IQ research found that 70% of organizations cite lack of internal capacity as the number one reason for outsourcing some or all of their production. A shortage of expertise (45%) was listed a major reason for outsourced manufacturing.

With regard to product type, the manufacture of finished form medicine is most commonly outsourced (7.27%), while 36.4% produce APIs and 31.8% manufacture biopharmaceuticals through external means.

See Also
Prescriptions for Supply Chain Success

Popular Sponsored Recommendations

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

Transformative Capabilities for XaaS Models in Manufacturing

Feb. 14, 2024
The manufacturing sector is undergoing a pivotal shift toward "servitization," or enhancing product offerings with services and embracing a subscription model. This transition...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!